Aptar Pharma is starting a technical collaboration with COVIRIX Medical, a feasibility study for a dry powder inhalation (DPI ...
Halozyme Therapeutics is appointing David Ramsay Interim Chief Financial Officer (CFO), effective March 23, 2026.
Novo Nordisk has signed an agreement with Hims & Hers Health that will allow the telehealth provider to offer FDA‑approved ...
Healthcare company Grail Inc.’s Chief Executive Officer (CEO) Bob Ragusa will retire in June. The company’s current President, Josh Ofman, MD, MSHS, will serve as CEO upon Ragusa’s retirement.
Colbert Packaging Corporation, a manufacturer of custom paperboard folding cartons, labels, and inserts, has installed an ...
NewcelX Ltd., a clinical-stage company, has entered a strategic collaboration with Eledon Pharmaceuticals Inc., a ...
Will expand manufacturing capacity at Lonza’s Houston facility to support growing demand for Genetix’s ZYNTEGLO ...
This article explores current OSD development and manufacturing trends from a CDMO perspective, including the evolution of ...
Lonza has entered into a definitive agreement to divest its Capsules & Health Ingredients (CHI) business to Lone Star Funds ...
Sotyktu (deucravacitinib) for treatment of adults with active psoriatic arthritis (PsA). Sotyktu is an oral, selective ...
“Partnering with Demeetra strengthens our ability to support biotech companies with a rapid and reliable path to GMP material ...
Spruce Biosciences Inc., a late-stage biopharmaceutical company focused on developing and commercializing novel therapies for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results